ReviewJournal of clinical pharmacy and therapeutics2011

Cancer 'survivor-care': I. the α7 nAChR as potential target for chemotherapy-related cognitive impairment.

R B RaffaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.